Coronavirus plasma treatment still experimental, cautions WHO
<p>The World Health Organization has cautioned that using blood plasma from COVID-19 survivors to treat other patients is still considered an experimental therapy. The United Nations agency today that preliminary study results are inconclusive and more rigorous research is underway. Yesterday, the US Food and Drug Administration authorized what’s called emergency use of the treatment […]</p>